Nebenwirkungen · Myocet liposomal (previously Myocet)
Myocet liposomal 50 mg powder, dispersion and solvent for concentrate for dispersion for infusion. · Abschnitt 4.8 · PDF-Seite 6
HOS-091145 · Präparat HOS-084209
The following adverse reactions have been reported with Myocet liposomal during clinical studies and post marketing experience. Adverse reactions are listed below as MedDRA preferred term by system organ class and frequency (frequencies are defined as: very common ≥1/10, common ≥1/100 to <1/10, uncommon ≥ 1/1,000 to <1/100, not known (cannot be estimated from the available data)).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-06-06T15:00:00Z · SHA-256 8f879c8b42a8f86dde725e12460699033047270c72b2613905f3d2414bc6cff4 · Passage 9e603bb46e9a3ecf4b4c52ba190ca7e2284c0e843ee19a2611f4d38d81aac122 · Zeichen 248–631 im Abschnitt